Globus Medical Schedules Third Quarter Earnings Release and Conference Call

Rhea-AI Summary

Globus Medical (NYSE:GMED) will announce third quarter results for the period ended September 30, 2025 after market close on Thursday, November 6, 2025. A copy of the release will be available on the company Investors website.

After the release, Globus Medical will host a teleconference and live webcast at 4:30 p.m. Eastern Time for the investment community. Telephone participants must register in advance to receive dial-in details, a unique passcode, and registrant ID. An audio archive will be posted on the Investors page after the call.

AUDUBON, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended September 30, 2025 after the market close on Thursday, November 6, 2025. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.

Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call live via webcast on the Investors page of Globus Medical’s website at https://www.investors.globusmedical.com/news-events/events-webcasts.

To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.

The audio archive will be available after the call on the Investors page of the Globus Medical website.

About Globus Medical, Inc.
Globus Medical, Inc. is a leading global musculoskeletal company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. Additional information can be accessed at www.globusmedical.com.

Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, the risks and costs associated with the integration of the NuVasive and Nevro businesses and our ability to successfully integrate and achieve anticipated synergies with the integration, health epidemics, pandemics and similar outbreaks, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, refer to the disclosure contained in our most recent annual report on Form 10-K filed with the U.S. Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time, and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.

Contacts:

Investors:
Brian Kearns
Senior Vice President, Corporate Development and Investor Relations
(610) 930-1800
investors@globusmedical.com

Media:
Moran Chavez
Senior Director, Corporate Communications
(619) 318-7681
media@globusmedical.com

FAQ

When will Globus Medical (GMED) release Q3 2025 earnings?

Globus Medical will release Q3 2025 results after market close on November 6, 2025.

What time is the Globus Medical (GMED) Q3 2025 conference call?

The teleconference and webcast are scheduled for 4:30 p.m. Eastern Time on November 6, 2025.

Where can I find the Globus Medical (GMED) Q3 2025 press release and webcast?

The press release and live webcast will be available on Globus Medical’s Investors page at https://www.investors.globusmedical.com.

How do I join the Globus Medical (GMED) November 6 conference call by phone?

Telephone participants must register in advance via the provided link to receive dial-in number, unique passcode, and registrant ID by email.

Will there be a replay of the Globus Medical (GMED) Q3 2025 call?

Yes. An audio archive of the call will be posted after the event on the company’s Investors page.

What period does Globus Medical’s Q3 2025 announcement cover for GMED?

The announcement covers the third quarter ended September 30, 2025.